IMMVENTION THERAPEUTIX

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases. It has a platform technology where it harnesses the immune system via biodegradable biopolymeric nano/micro-particles. The company's expertise targets auto-inflammatory ailments for which there are large unmet wants, together with rheumatoid arthritis, osteoarthritis, gout, and Alzheimer’s illness. Its illness-modifying therapies inhibit irritation attributable to inflammasomes that activate inflammatory responses. The corporate makes use of its platform to find small-molecule inhibitors of a number of inflammatory receptors.